QPS Clinical NL June 2026

Greetings!

Welcome to the Monthly QPS Clinical Newsletter

Discover how QPS can streamline your clinical trials with seamless Central Safety Laboratory testing and PBMC processing solutions, and explore the latest insights on chronic pain treatment and a promising new Lyme disease vaccine.

A Trusted Partner for Clinical Trial Safety Testing

At QPS, a full suite of laboratory testing solutions delivers the compliance, accuracy, and efficiency your clinical trial demands. Let us handle the kit logistics and sample testing so your team can spend more time focusing on patient outcomes and study success.

Discover More

Streamline Your Trial Today!

Trust QPS for PBMC Processing

QPS delivers standardized peripheral blood mononuclear cell (PBMC) processing solutions to ensure sample integrity, reproducibility, and high-quality downstream data.

Our PBMC processing services support both early-stage research and large-scale clinical trials.

QPS combines scientific expertise with global infrastructure to deliver reliable PBMC CRO services for immunology, vaccine, and cell therapy programs.

Request a PBMC Processing Quote

Discover the Future of Science on the QPS Blog

Flipping a Switch to Stop Chronic Pain

Public health experts estimate that up to 10 percent of adults are newly diagnosed with chronic pain, or ongoing pain that lasts longer than…

Mapping Chronic Pain Pathways

QPS Clinical Trial Services

Clinical Trial Results Revive Long-Awaited Lyme Disease Vaccine Effort

After more than two decades without a human vaccine for Lyme disease, a new candidate is showing measurable progress. Clinical trial data reported by…

A New Chapter in Lyme Prevention

More Vaccine Research at QPS

Subscribe to the QPS Blog

Contact the Experts at QPS

Request a meeting with QPS preclinical, bioanalysis, translational medicine, and/or clinical research subject matter experts today.

Contact QPS Today

Visit our website www.qps.com

or contact us at infopr@qps.com

to start your next study.

View as Webpage

www.qps.com | infopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)